Browse > Article

Preparation of Prolonged Release Clarithromycin Microparticles for Oral Use and Their In Vitro Evaluation  

Genc, Lutfi (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology,Plant, Drug & Scientific Researches Center of Anadolu University (AUBIBAM))
Demirel, Muzeyyen (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology)
Yazan, Yasemin (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology)
Publication Information
Archives of Pharmacal Research / v.29, no.10, 2006 , pp. 921-927 More about this Journal
Abstract
Prolonged release micro particles of clarithromycin (CL) were prepared using Eudragit RL 100 and RS 100 by spray-drying and casting-drying techniques. For the characterization of those microparticles, preparation yield, particle size distribution, X-ray diffraction, thermal behavior, active agent content and in vitro dissolution from the microparticles were performed. HPLC was used for the assay of clarithromycin and the assay method was validated. All the formulations obtained showed prolonged release when compared to pure clarithromycin. Microparticles prepared by spray-drying method had a slower release compared to those of casting drying method. Spray-drying method seems to be a more suitable method to prepare microparticles for prolongation in release.
Keywords
Prolonged release; Microparticle; Clarithromycin; Eudragit RL 100 and RS 100; Spray-drying; Casting-drying;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Adam, D., Glaser-Caldow, E., Wachter, J., Brueckner, O.-J., Hein, J., Kroemer, B., and Hirsch, J., Comparative efficacy of clarithromycin modified rlelase and immediate relaese formulations in the treatment of lower respiratory tract infection. Clin. Ther., 23(4), 585-595 (2001)   DOI   ScienceOn
2 Bele, M., Dmitrasinovic, D., Planinsek, O., Salobir, M., Srcic, S., Gabescek, M., and Jamnik, J., Silica coating on clarithromycin. Int. J. Pharm., 291, 149-153 (2005)   DOI   ScienceOn
3 Chu, S.-Y., Sennello, L. T., and Sonders, R. C., Simultaneous determination of clarithromycin and 14-hydroxy-clarithromycin in plasma and urine using HPLC with electronical detection. J. Chromatogr., 571, 199-208 (1991)   DOI   ScienceOn
4 Conte, J. E., Golden, J. A., Duncan, S., Mckenna, E., and Zurlinden, E., Intra-pulmonar pharmacokinetics of clarithromycin and of erythromycin. Antimicrob. Agents Chemother., 39(2), 334-338 (1995)   DOI   ScienceOn
5 Martin, T. M., Bandi, N., Shulz, R., Roberts, C. B., and Kompella, U. B., Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology. AAPS PharmSci. Tech., 3(3), 1-11 (2002)
6 Yonemochi, E., Kitahara, S., Maeda, S., Yamamura, S., Oguchi, T., and Yamoto, K., Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. Eur. J. Pharm. Sci., 7, 331-338 (1999)   DOI   ScienceOn
7 Perng, C. Y., Kearney, A. S., Patel, K., Palepu, N. R., and Zuber, G., Investigation of formulation approaches to improve the dissolution of SB-210661 a poorly water soluble 5-Lipoxygenase inhibitor. Int. J. Pharm., 176, 31-38 (1998)   DOI   ScienceOn
8 Louis, St., Drug Facts and Comparisons. A Wolters Kluwer Company, USA, p.2189 (1997)
9 Mu, l., Teo, M.-M., Ning, H.-Z., and Feng, S.-S., Novel powder formulations for controlled delivery of poorly soluble anticancer drug: Application and investigation of TPGS and PEC in spray-dried particulate system. J. Control. Release, 103, 565-575 (2005)   DOI   ScienceOn
10 Pav, B., Misztal, G., Hopkala, H., and Drozd, J., Development and validation of a HPLC method for the determination of cetrizine in pharmaceutical dosage forms. Pharmazie, 57, 313-315 (2002)
11 Beuving, G., Validation of Analytical Methods. Validation Seminar, Istanbul, 31 May- 01 June 2001
12 U. S. Pharmacopeia National Formulary, USP 26-NF 21, 3th Ed.,Mack Printing Company: Easton, U.S.A., pp. 2439-2445 (2003)
13 Guay, D. R. P., Gustavson, L. E., Devcich, K. J., Zhang, J., Cao, G., and Olson, C.A., Pharmacokinetics and tolerability of extended-release clarithromycin. Clin. Ther., 23(4), 566-577 (2001)   DOI   ScienceOn
14 LI, Y., Zhu, K. J., Zhang, J. X., Jiang, H. L., Liu, J. H., Hao, Y. L., Yasuda, H., Ichimaru, A., and Yamamoto, K., In vitro and in vivo studies of cyclosporin A-Loaded microspheres based on copolymers of lactide and $\varepsilon$-Caprolactone: Comparison with Conventional PLGA Microspheres. Int. J. Pharm., 295, 67-76 (2005)   DOI   ScienceOn
15 Barradell, L. B., Plosker, G. L., and Mctavish, D., Clarithromycin: A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with Acquired Immune Deficiency Syndrome. Drugs, 46(2), 289-312 (1993)   DOI   ScienceOn
16 Erah, P. O., Goddard, A. F., Barrett, D. A., Shaw, P. N., and Spillr, R. C., The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J. Antimicrob. Chemother., 39, 5-12 (1997)   DOI   ScienceOn
17 Oneda, F. and Ré, M. I., The effect of formulation variables on the dissolution and physical properties of spray-dried microspheres containing organic salts. Powder Technol., 130, 377-384 (2003)   DOI   ScienceOn
18 Kim, S. J., Hahn, S. K., Kim, M. J., Kim, D. H., and Lee, Y. P., Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles. J. Control. Release, 104, 323- 335 (2005)   DOI   ScienceOn
19 Rotsch, T. D., Spanton, M., Cugier, P., and Plasz, A. C., Determination of clarithromycin as a conta-minant on surfaces by HPLC using electronical detection. Pharm. Res., 8(8), 989- 991 (1991)   DOI
20 Morgan, D. K., Brown, D. M., Rotsch, T. D., and Plasz, A. C., A reversed-phase HPLC method for the determination and identification of clarithromycin as the drug substance and in various dosage forms. J. Pharm. Biomed. Anal., 9(3), 261- 269 (1991)   DOI   ScienceOn
21 Reiley, C. M. and Fell, F., Development and validation of analytical methods. Prog. Pharm. Biomed. Anal., 3, 20-22 (1996)
22 Nakagawa, Y., Itai, S., Yoshida, T., and Nagai, T., Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chem. Pharm. Bull., 40(3), 725-728 (1992)   DOI   ScienceOn